Indeed, NGS revealed that 53% of 183 Mayo Clinic ET patients harbored one or more sequence variants/mutations other than JAK2/CALR/MPL, being TET2 and ASXL1 the most frequent ones. The gene discussed is CALR; the disease is essential thrombocythemia.